Bioxel Pharma Inc.
|
|||
| Mailing Address: | Siege Social / Head Office 2050, boul. René-Lévesque Ouest Suite 104 Québec, Québec G1V 2K8 |
Head Office Address: | Siege Social / Head Office 2050 boul. René-Lévesque Ouest Suite 104 Québec, Québec G1V 2K8 |
| Contact Name: | Me Gilles Reny | Principal Regulator: | Quebec |
| Business e-mail address: | greny@grondinpoudrier.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 418 683-3000 | Reporting Jurisdictions: | British Columbia, Alberta, Ontario, Quebec |
| Fax Number: | 418 683-0677 | Stock Exchange: | TSX Venture |
| Date of Formation: | Jul 13 1995 | Stock Symbol: | BIP |
| Jurisdiction Where Formed: | Federal | Auditor: | Raymond Chabot Grant Thornton |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 09069J | Transfer Agent: | Computershare Investor Services Inc. |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $5,000,001 to $25,000,000 |
|
